Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $0.724 is 47.76% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 0.75||$ 1.52|
|Low:||$ 0.70||$ 0.49|
Company Description (as filed with the SEC)
Unless the context requires otherwise, references in this Annual Report on Form 10-K to "Genocea", "we", "us" and "our" refer to Genocea Biosciences, Inc. Overview We are a biopharmaceutical company that discovers and develops novel cancer vaccines. We use our proprietary discovery platform, ATLAS, to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. We believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, we announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of our research programs and product candidates in active development are at the preclinical stage. ... More ...
Nasdaq Official Price
Oct. 19, 2018
Oct. 19, 2018